EXENS Share Price Performance
€67.90
35.95 (112.52%)
11.3% overvalued intrinsic discount
€61.00
Fair Value
Price €67.90
AnalystHighTarget €61.00
AnalystConsensusTarget €64.83
AnalystLowTarget €39.06
Fair Value€61.00
Share Pricen/a
Exosens Stock Price
- 3 Narratives written by author
- 1 Comments on narratives written by author
- 25 Fair Values set on narratives written by author
EXENS Community Narratives
AN
Fair Value €61 11.3% overvalued intrinsic discount
Accelerated Digitization And Expanding Defense Spending Will Spur Sensor Demand
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
Fair Value €64.83 4.7% overvalued intrinsic discount
EXENS: Defense Sector Demand And Shareholder Shift Will Shape Outlook
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
Fair Value €39.06 73.8% overvalued intrinsic discount
Geopolitical Instability Will Pressure Global Defense Margins
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
EXENS: Defense Sector Demand And Shareholder Shift Will Shape Outlook
Key Takeaways Increased global defense spending and Exosens' leadership in advanced sensing technologies support strong and sustained demand across diversified end-markets. Expanded production capacity, product innovation, and financial flexibility position Exosens for long-term growth, operating efficiency, and enhanced profitability.Read more
111
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
€64.83
4.7% overvalued intrinsic discount
AnalystConsensusTarget's Fair Value
Revenue
13.51% p.a.
Profit Margin
18.49%
Future PE
31.52x
Price in 2029
€79.03
Geopolitical Instability Will Pressure Global Defense Margins
Key Takeaways Exposure to geopolitical instability, ESG pressures, and reliance on defense make Exosens vulnerable to regulatory, supply chain, and market volatility risks. Failure to innovate and diversify, combined with evolving industry technology, threatens margin erosion and long-term earnings sustainability.Read more
13
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
€39.06
73.8% overvalued intrinsic discount
AnalystLowTarget's Fair Value
Revenue
13.76% p.a.
Profit Margin
17.27%
Future PE
21.82x
Price in 2029
€47.17
Accelerated Digitization And Expanding Defense Spending Will Spur Sensor Demand
Key Takeaways Exosens' global reach, modular capacity expansion, and unique positioning enable it to outperform competitors and capture market share as demand surges worldwide. Deep integration in next-gen sectors and proven M&A execution fuel recurring revenues, diversified growth, and resilient margins across economic cycles.Read more
24
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
€61
11.3% overvalued intrinsic discount
AnalystHighTarget's Fair Value
Revenue
15.85% p.a.
Profit Margin
18.43%
Future PE
30.22x
Price in 2029
€73.67
Trending Discussion
Recently Updated Narratives
AN
EXENS: Defense Contracts And New Shareholder Support Will Underpin Measured Outlook
Fair Value: €64.83 4.7% overvalued intrinsic discount
2 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
EXENS: Future Defense Contracts Will Still Reveal Extended Overvaluation Risk
Fair Value: €39.06 73.8% overvalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
EXENS: Defense Contracts And New Shareholder Support Will Strengthen Future Earnings Power
Fair Value: €61 11.3% overvalued intrinsic discount
1 followerusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Exosens Key Details
Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
Jul 28, 2026
- 1.38
- 60.06%
- 14.99%
- 56.1%
About EXENS
- Founded
- 1937
- Employees
- 1499
- CEO
- WebsiteView website
Exosens engages in the development, manufacture, and sale of electro-optical technologies in the fields of amplification, and detection and imaging in France, rest of Europe, North America, Asia, Oceania, Africa, and internationally. It offers image intensifier tubes; ultraviolet, short, medium, and long wave infrared, visible - near infrared, and mid-wave infrared cameras, as well as enhanced vision equipment; ion and electron, scintillation, and single photon detection products; x-ray components, neutronic imaging products, and image intensifiers for scientific applications; and gamma and neutron detectors, and mineral insulated extensions. The company also provides power tubes and microwave devices; and methane airborne detection solutions. It operates under the Photonis, Xenics, Telops, and El-Mul brand names. The company serves defense and surveillance, life sciences, industrial control and nuclear markets. The company was founded in 1937 and is based in Mérignac, France.
